EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy

Annika van Hummel iD, Goce Taleski, Jean-Marie Sontag, Astrid Feentje Feiten, Yazi D Ke iD, Lars M Ittner, Estelle Sontag

Neuropathology and Applied Neurobiology · 2023-08 · 49 (4)

DOI: 10.1111/nan.12931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 28.08.2023. Verfasst von Annika van Hummel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Au…. Hauptthemen laut MEDLINE: Tauopathies, Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunter Medical Research Institute, Motor Neurone Disease Research Australia, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reduced folate status and elevated levels of circulating homocysteine are modifiable risk factors for cognitive decline and dementia. Disturbances in one‐carbon metabolism are associated with the pathological accumulation of phosphorylated tau, a hallmark feature of prevalent dementia, including Alzheimer's disease and subgroups of frontotemporal dementia.

Methods

Here, using transgenic TAU58/2 mouse models of human tauopathy, we tested whether dietary supplementation with L‐methylfolate (the active folate form), choline and betaine can reduce tau phosphorylation and associated behavioural phenotypes.

Results

TAU58/2 mice fed with the methyl donor‐enriched diet showed reduced phosphorylation of tau at the pathological S202 (CP13) and S396/S404 (PHF‐1) epitopes and alleviation of associated motor and learning deficits. Compared with mice on the control diet, the decrease in cortical phosphorylated tau levels in mice fed with the methyl donor‐enriched diet was associated with enhanced methylation of protein phosphatase 2A, the major brain tau Ser/Thr phosphatase. It also correlated with a reduction in protein levels of Fyn, a tau tyrosine kinase that plays a central role in mediating pathological tau‐induced neurodegeneration. Conversely, Fyn expression levels were increased in mice with deficiencies in folate metabolism.

Conclusions

Our findings provide the first experimental evidence that boosting one‐carbon metabolism with L‐methylfolate, choline and betaine can mitigate key pathological, learning and motor deficits in a tauopathy mouse model. They give support to using a combination of methyl donors as a preventive or disease‐modifying strategy for tauopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TauopathiesAlzheimer DiseaseMiceHumansAnimalsProtein Phosphatase 2tau ProteinsBetaineMice, TransgenicPhosphorylationDisease Models, AnimalFolic AcidCholineDietary SupplementsCarbon

Stichwörter der Autor:innen

Alzheimer's diseaseFynPP2ATaufolatemethylationone-carbon metabolismtauopathy

Substanzen

Protein Phosphatase 2tau ProteinsBetaineFolic AcidCholineCarbon

Autor:innen und Institutionen

  • Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia.
  • Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.

ORCID-Profile: Annika van Hummel, Yazi D Ke

Förderung

  • Hunter Medical Research Institute
  • Motor Neurone Disease Research Australia
  • National Health and Medical Research Council

Zitieren

APA

van Hummel, A., Taleski, G., Sontag, J. M., Feiten, A. F., Ke, Y. D., Ittner, L. M., & Sontag, E. (2023). Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy. Neuropathology and Applied Neurobiology, 49(4). https://doi.org/10.1111/nan.12931

Vancouver

van Hummel A, Taleski G, Sontag JM, Feiten AF, Ke YD, Ittner LM, et al. Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy. Neuropathology and Applied Neurobiology. 2023;49(4). doi:10.1111/nan.12931

BibTeX
@article{vanHummel2023,
  author = {van Hummel, Annika and Taleski, Goce and Sontag, Jean-Marie and Feiten, Astrid Feentje and Ke, Yazi D and Ittner, Lars M and Sontag, Estelle},
  title = {Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2023},
  volume = {49},
  number = {4},
  doi = {10.1111/nan.12931}
}
Kostenlos starten →